- Home
- SYRE vs TGB Comparison
SYRE vs TGB Comparison
Compare SYRE & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | TGB |
|---|---|---|
| Founded | 2013 | 1966 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | TGB |
|---|---|---|
| Price | $33.30 | $7.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $56.50 | $5.00 |
| AVG Volume (30 Days) | 795.0K | ★ 7.3M |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $428,559,326.00 |
| Revenue This Year | N/A | $10.35 |
| Revenue Next Year | N/A | $61.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.50 |
| 52 Week Low | $10.91 | $1.67 |
| 52 Week High | $35.31 | $7.43 |
Technical Indicators
Market Signals| Indicator | SYRE | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 73.05 |
| Support Level | $30.00 | $5.68 |
| Resistance Level | $34.21 | $7.43 |
| Average True Range (ATR) | 1.83 | 0.31 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 84.46 | 79.31 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.